RFCA
DVAX

R&F Capital Advisors’s Dynavax Technologies DVAX Stock Holding History

R&F Capital Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$77K Sell
12,924
-31,462
-71% -$151K 0.02% 630
2016
Q4 		$175K Buy
+44,386
New +$325K 0.06% 422

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

R&F Capital Advisors's DVAX Position: Q1 2017 in Review

R&F Capital Advisors reduced its Dynavax Technologies (DVAX) stake by 71% in Q1 2017, selling an estimated $151K and leaving 12,924 shares worth $77K. The position accounts for 0.02% of the portfolio, ranked #630.

R&F Capital Advisors first reported a position in DVAX in Q4 2016 and has held it in 2 quarters since. The position peaked at $175K in Q4 2016. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

  • R&F Capital Advisors held 12,924 shares of Dynavax Technologies worth $77K as of Q1 2017.
  • R&F Capital Advisors sold 31,462 Dynavax Technologies shares in Q1 2017, an estimated $151K.
  • Dynavax Technologies made up 0.02% of R&F Capital Advisors's portfolio in Q1 2017, its #630 holding.
  • R&F Capital Advisors first reported a position in Dynavax Technologies in Q4 2016 and has held it in 2 quarters since.
  • R&F Capital Advisors's Dynavax Technologies position peaked at $175K in Q4 2016.
  • 101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.